Neurology, Neuropsychiatry, Psychosomatics

Advanced search

PHARMACOEPIDEMIOLOGICAL PARAMETERS OF USE OF POTENT OPIOIDS IN SAINT PETERSBURG (in the light of differences in approaches to using the drugs of this group in Russia and in the world)

Full Text:


The paper considers the pharmacoepidemiological parameters of the use of potent opioids in Saint-Petersburg in 2000-2009. These parameters are compared with those in a number of countries of the world, particularly in the Scandinavian countries that are close to Saint Petersburg in population. The reasons for the differences in the use of potent analgesics are analyzed. Approaches to prescribing the drugs of this group for non-cancer pain caused by neurological diseases in particular are also analyzed.

About the Authors

M. V. Pchelintsev
Acad. I.P. Pavlov Saint-Petersburg Medical University
Russian Federation

E. E. Zvartau
Acad. I.P. Pavlov Saint-Petersburg Medical University
Russian Federation

A. N. Kubynin
Acad. I.P. Pavlov Saint-Petersburg Medical University
Russian Federation


1. <div><p>Bergman U. et al., eds. Studies in drug utilization. Methods and applications. Copenhagen, WHO Regional Office for Europe, 1979 (WHO Regional Publications, European Series № 8).</p><p>De Conno F., Ripamonti C., Brunelli C. Opioid purchases and expenditure in nine western European countries: «Are we killing off morphine?» J Palliative Medicine 2005;19:179-84.</p><p>Hamunen K., Laitinen-Parkkonen P.,Paakkari P. What do different databases tell about the use of opioids in seven European countries in 2002? Eur J Pain 2008;12(6):705-15.</p><p>Hamunen K., Paakkari P., Kalso E. Trends in opioid consumption in the Nordic countries 2002-2006. Eur J Pain 2009;13(9):954-62.</p><p>Hudec R., Tisonova J., Bozekova L., Foltan V. Trends in consumption of analgesics in Slovak Republic during 1998-2002. Eur J Clin Pharmacol 2004;60(6):445-8.</p><p>Яхно Н.Н., Насонов Е.Л. Неспецифическая боль в нижней части спины. Диагностика, лечение, предупреждение. М.: ООО «КомплектСервис», 2008.</p><p>Ананьева Л.П. Применение наркотических анальгетиков при лечении хронической неонкологической боли. РМЖ 2008;(16):21-7.</p><p>Дроздов В.Н. Основные принципы применения опиатов при хронической неонкологической боли. РМЖ 2007;15(4):237-41.</p><p>Кукушкин М.Л. Принципы использования опиоидов при хронической нераковой боли. РМЖ 2007;(24):1766-72.</p><p>Эрдес Ш.Ф. Использование опиоидных анальгетиков в ревматологической практике. Боль 2008;(1):24-8.</p><p>Kalso E., Allan L., Dellemijn P.L.I. Recommendations for using opioids in chronic non-cancer pain. Eur J Pain 2003;7:381-6.</p><p>Simpson R.K. Opioids for persistent noncancer pain: recommendations for clinical practice. Br J Anaesth 2004;92:326-8.</p><p>Caldwell J.R., Hale M.E., Boyd R.E. et al. Treatment of osteoarthritis pain with controlled release oxycodone or fixed combination oxy- codone plus acetaminophen added to nons- teroidal antiinflammatory drugs: a double blind, randomized, multicenter, placebo controlled trial. J Rheumatology 1999;26:862-9.</p><p>Caldwell J.R., Rapoport R.J., Davis J.C. et al. Efficacy and safety of a once-daily morphine formulation in chronic, moderate-to-severe osteoarthritis pain: results from a randomized, placebo-controlled, double-blind trial and an open-label extension trial. J Pain Symptom Manage 2002;23:278-91.</p><p>Peloso P.M., Bellamy N., Bensen W. et al. Double blind randomized placebo-control trial of controlled release codeine in the treatment of osteoarthritis of the hip or knee. J Rheumatol 2000;27:764-71.</p><p>Jamison R.N., Raymond S.A., Slawsby E.A. et al. Opioid therapy for chronic noncancer back pain: a randomized prospective study. A randomized-prospective study. Spine 1998;23:2591-600.</p><p>Gimbel J.S., Richards P., Portenoy R.K. Controlled-release oxycodone for pain in dia- betic neuropathy: a randomized controlled trial. Neurology 2003;60:927-34.</p><p>Watson C.P.N., Moulin D., Watt-Watson J. et al. Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy. Pain 2003;105:71-8.</p><p>Argoff C.E., Katz N., Backonja M. Treatment of post-herpetic neuralgia: a review of therapeutic options. J Pain Symptom Manage 2004;28(4):396-411.</p><p>Huse E., Larbig W., Flor H. et al. The effect of opioids on phantom limb pain and cortical reorganization. Pain 2001;90:47-55.</p><p>Morley J.S., Bridson J., Nash T.P. et al. Low-dose methadone has an analgesic effect in neuropathic pain: a double-blind randomized controlled crossover trial. Palliat Med 2003;17:576-87.</p><p>Rowbotham M.C., Twilling L., Davies P.S. Oral Opioid Therapy for chronic peripheral and central neuropathic Pain. N Engl J Med 2003;348:1223-32.</p><p>Furlan A.D., Sandoval J.A., Mailis-Gagnon A., Tunks E. Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects. CMAJ 2006;174:11.</p><p>Breivik H. Opioids in chronic non-cancer pain, indications and controversies. Eur J Pain 2005;9:127-30.</p><p>Kalso E., Edwards J.E., Moore R.A. et al. Opioids in chronic non-cancer pain: systematic review of efficacy and safety. Pain 2004;112:372-80.</p><p>Butler S.F., Budman S.H., Fernandez K., Jamison R.N. Validation of a screener and opioid assessment measure for patients with chronic pain. Pain 2004;112(1-2):65-75.</p><p>Chabal C., Erjavec M.K., Jacobson L. et al. Prescription opiate abuse in chronic pain patients: clinical criteria, incidence and predictors. Clin J Pain 1997;13:150-5.</p><p>Compton P., Darakjian J., Miotto K. Screening for addiction in patients with chronic pain with problematic substance use: evaluation of a pilot assessment tool. J Pain Symptom Manage 1998;16:355-63.</p><p>Fishbain D.A., Rosomoff H.L.,Rosomoff R.S. Drug abuse, dependence and addiction in chronic pain patients. Clin J Pain 1992;8:77-85.</p><p>Gilson A.M., Ryan K.M., Joranson D.E. et al. A reassessment of trends in the medical use and abuse of opioid analgesics and implications for diversion control. J Pain Symptom Manage 2004;28:176-88.</p><p>Gourlay D.L., Heit H.A., Almahrezi A. Universal precautions in pain medicine: a rational approach to the treatment of chronic pain. Pain Med 2005;6:107-12.</p><p>Katz N.P., Sherburne S., Beach M. et al. Behavioral monitoring and urine toxicology testing in patients receiving long-term opioid therapy. Anesth Analg 2003;97:1097-102.</p><p>Makin M.K. New directions in opioid use. Journ Roy Soc Med 2001:94:17-21.</p><p>Adams Gatchel R.J., Robinson R.C. Development of self-report screening instrument for assessing potential opioid medication misuse in chronic pain patients. J Pain Symptom Manage 2004;27:440-59.</p><p>Brown R.L., Rounds L.A. Conjoint screening questionnaires for alcohol and other drug abuse: criterion validity in primary care practice. Wis Med J 1995;94:135-40.</p><p>Coombs R.B., Jarry J.L., Santhiapillai A.C. The SISAP: a new screening instrument for identifying potential opioid abuse in the management of chronic nonmalignant pain in general medical practice. Pain Res Manage 1996;1:155-62.</p><p>Coluzzi F., Pappagallo M. Opioid therapy for chronic noncancer pain: practice quidelines for initiation and maintenance of therapy. Minerva Anestesiol 2005;71:425-33.</p><p>Kahan M., Srivastava A., Wilson L. Opioids for managing chronic non-malignant pain: safe and effective prescribing. Can Fam Physician 2006;52(12):1091-6.</p><p>Tedeschi M. Chronic nonmalignant pain - the rational use of opioid medication. Aust Fam Physician 2006;35(7):509-12.</p><p>Allan L., Hays H., Jensen N.H. et al. Randomised crossover trial of transdermal fentanyl and sustained release oral morphine for treating chronic non-cancer pain. BMJ 2001;322(7295):1134-58.</p><p>Allan L., Richarz U., Simpson K., Slappendel R. Transdermal fentanyl versus sustained release oral morphine in strong-opioid nalve patients with chronic low back pain. Spine 2005;30(22):2484-90.</p><p>Rauck R.L., Bookbinder S.A., Bunker T.R. A randomized, open-label study of once-a-day AVINZA (morphine sulfate extended-release capsules) versus twice-a-day OxyContin (oxy- codone hydrochloride controlled-release tablets) for chronic low back pain: the extension phase of the ACTION trial. J Opioid Manag 2006;2(6):325-8, 331-3.</p><p>Rauck R.L., Bookbinder S.A., Bunker T.R. The ACTION study: a randomized, open-label, multicenter trial comparing once-a-day extend- ed-release morphine sulfate capsules (AVINZA) to twice-a-day controlled-release oxycodone hydrochloride tablets (OxyContin) for the treatment of chronic, moderate to severe low back pain. J Opioid Manag 2006;2(5):276.</p><p>Rosenthal M., Moore P., Groves E. et al. Sleep improves when patients with chronic OA pain are managed with morning dosing of once a day extended-release morphine sulfate (AVINZA): findings from a pilot study. J Opioid Manag 2007;3(3):145-54.</p><p>Simpson R.K. Jr., Edmondson E.A., Constant C.F., Collier C. Transdermal fentanyl as treatment for chronic low back pain. Pain Symptom Manage 1997;14(4):218-24.</p><p>Nicholson B., Ross E., Weil A. et al. Treatment of chronic moderate-to-severe non-malignant pain with polymer-coated extended-release morphine sulfate capsules. Curr Med Res Opin 2006;22(3):539-50.</p><p>Nicholson B., Ross E., Sasaki J., Weil A. Randomized trial comparing polymer-coated extended-release morphine sulfate to controlled-release oxycodone HCl in moderate to severe nonmalignant pain. Curr Med Res Opin 2006;22(8):1503-14.</p><p>Milligan K., Lanteri-Minet M.,Borchert K. et al. Evaluation of long-term effi- cacy and safety of transdermal fentanyl in the treatment of chronic noncancer pain. J Pain 2001;2(4):195-6.</p><p>Ringe J.D., Faber H., Bock O. Transdermal fentanyl for the treatment of back pain caused by vertebral osteoporosis. Rheumatol Int 2002;22(5):199-203.</p></div><br />

For citation:

Pchelintsev M.V., Zvartau E.E., Kubynin A.N. PHARMACOEPIDEMIOLOGICAL PARAMETERS OF USE OF POTENT OPIOIDS IN SAINT PETERSBURG (in the light of differences in approaches to using the drugs of this group in Russia and in the world). Neurology, Neuropsychiatry, Psychosomatics. 2009;1(3-4):47-52. (In Russ.)

Views: 393

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 2074-2711 (Print)
ISSN 2310-1342 (Online)